Outcome of allogeneic stem cell transplantation in myelodysplastic syndrome patients: prognostic implication of monosomal karyotype

The Novel 5-Group Cytogenetic Risk Classification of Myelodysplastic Syndrome (MDS), Monosomal Karyotype, and Outcome After Allogeneic Hematopoietic Cell Transplantation (HCT)

(2012) A. Gerds et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Autosomal monosomies among 24,262 consecutive cytogenetic studies: Prevalence, chromosomal distribution and clinicopathologic correlates of sole abnormalities

(2011) Sania Raza et al.   AMERICAN JOURNAL OF HEMATOLOGY

Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity

(2011) Hee Kyung Ahn et al.   AMERICAN JOURNAL OF HEMATOLOGY

Partial and total monosomal karyotypes in myelodysplastic syndromes: Comparative prognostic relevance among 421 patients

(2011) Carolina B. Belli et al.   AMERICAN JOURNAL OF HEMATOLOGY

Myeloablative Reduced-Toxicity i.v. Busulfan-Fludarabine and Allogeneic Hematopoietic Stem Cell Transplant for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in the Sixth through Eighth Decades of Life

(2011) Gheath Alatrash et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities

(2011) A. Perrot et al.   BLOOD

Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies

(2011) S. Kayser et al.   BLOOD

Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation

(2011) M. Fang et al.   BLOOD

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

(2011) F. G. Rucker et al.   BLOOD

Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome

(2011) Stefanie Buchholz et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial

(2011) M. Stelljes et al.   HAEMATOLOGICA

Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine

(2011) R Itzykson et al.   LEUKEMIA

Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome: A Review

(2011) Simrit Parmar et al.   SEMINARS IN ONCOLOGY

Monosomal Karyotype Provides Better Prognostic Prediction after Allogeneic Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia

(2010) Betul Oran et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience

(2010) B. C. Medeiros et al.   BLOOD

Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype

(2010) M M Patnaik et al.   LEUKEMIA

Allogeneic Stem Cell Transplantation for Adults with Myelodysplastic Syndromes: Importance of Pretransplant Disease Burden

(2009) Erica D. Warlick et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype

(2008) Dimitri A. Breems et al.   JOURNAL OF CLINICAL ONCOLOGY